e-learning
resources
ERJ
2004
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
STAT4 activation in smokers and patients with chronic obstructive pulmonary disease
Di Stefano A., Caramori G., Capelli A., Gnemmi I., Ricciardolo F.L., Oates T., Donner C.F., Chung K.F., Barnes P.J., Adcock I.M.
Source:
Eur Respir J 2004; 24: 78-85
Journal Issue:
July
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Di Stefano A., Caramori G., Capelli A., Gnemmi I., Ricciardolo F.L., Oates T., Donner C.F., Chung K.F., Barnes P.J., Adcock I.M.. STAT4 activation in smokers and patients with chronic obstructive pulmonary disease. Eur Respir J 2004; 24: 78-85
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Decreased FOXP3 expression in small airways of smokers with COPD
Source: Eur Respir J 2009; 33: 61-67
Year: 2009
Lymphocyte population and apoptosis in the lungs of smokers and their relation to emphysema
Source: Eur Respir J 2001; 17: 946-953
Year: 2001
Expression profile of Th1/Th2 transcription factors T-bet and GATA-3 in sarcoidosis, idiopathic pulmonary fibrosis and chronic obstructive pulmonary disease
Source: Annual Congress 2010 - Usefulness of bronchoalveolar lavage in diffuse parenchymal lung disease
Year: 2010
Autoimmunity, T-cells and STAT-4 in the pathogenesis of chronic obstructive pulmonary disease
Source: Eur Respir J 2004; 24: 3-5
Year: 2004
A high probability of short-range interactions between fibrocytes and CD8+ T cells potentiates the inflammatory response in chronic obstructive pulmonary disease (COPD) lungs
Source: Virtual Congress 2020 – Host-microbe interactions and their influence on lung disease onset and severity
Year: 2020
Evidence of mast-cell activation in a subset of patients with eosinophilic chronic obstructive pulmonary disease
Source: Eur Respir J 2002; 20: 325-331
Year: 2002
STAT4 activation in smokers and patients with chronic obstructive pulmonary disease
Source: Eur Respir J 2003; 22: Suppl. 45, 359s
Year: 2003
Enhanced expression of proinflammatory cytokine (IL-18) and its receptor in patients with chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2006; 28: Suppl. 50, 551s
Year: 2006
Expression profiling of Th17 associated molecules in bronchoalveolar cells from patients with chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2011 - COPD: clinical studies and animal cell models
Year: 2011
Decreased TCR γδ T lymphocytes in patients with chronic obstructive pulmonary disease
Source: Eur Respir J 2003; 22: Suppl. 45, 85s
Year: 2003
The role of regulator and effector T lymphocytes in chronic obstructive pulmonary disease and lung cancer
Source: Annual Congress 2010 - Pathology of lung cancer
Year: 2010
Pulmonary dendritic cells from chronic obstructive pulmonary disease patients suppress lung immune responses through induction of regulatory T cells
Source: Annual Congress 2011 - T-cell subsets
Year: 2011
The relationship of the transcription factors AP-1 and NF-
KB
with lung function in the lungs of patients with chronic obstructive pulmonary disease
Source: Eur Respir J 2001; 18: Suppl. 33, 501s
Year: 2001
Decreased pulmonary immunoregulatory/suppressor (CD4+CD25+) T-lymphocytes in chronic obstructive pulmonary disease
Source: Eur Respir J 2003; 22: Suppl. 45, 85s
Year: 2003
A high probability of short-range interactions between fibrocytes and CD8 T cells in chronic obstructive pulmonary disease (COPD) lungs
Source: International Congress 2019 – Novel mechanisms elucidated by translational studies of COPD
Year: 2019
High ICAM-1 gene expression in pulmonary fibroblasts of COPD patients: a reflection of an enhanced immunological function
Source: Eur Respir J 2006; 28: 113-122
Year: 2006
Lung dendritic cells from chronic obstructive pulmonary disease patients induce type 1 T regulatory cells
Source: Annual Congress 2012 - Immunologic mechanisms in COPD and asthma
Year: 2012
COPD is associated with reduced pulmonary interstitial expression of pentraxin-3
Source: Eur Respir J 2012; 39: 830-838
Year: 2012
Micro-RNA-125a/b target A20 and MAVS to promote inflammatory and impair antiviral responses in chronic obstructive pulmonary disease
Source: International Congress 2016 – Mechanisms of disease
Year: 2016
Airway epithelium, lymphocyte, neutrophil and macrophage apoptosis in chronic obstructive pulmonary disease
Source: Annual Congress 2008 - Basic science in asthma and COPD II
Year: 2008
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept